Advanced Search

MDS Alert

Tool:

Know the 'Adverse Consequences of Antipsychotics' Listed in the CAA Resource

Published on Wed Mar 28, 2012

The "Review of Indicators of Psychotropic Drug Use" in the RAI manual's Care Area Assessment Resource for Psychotropic Medication Use includes this verbatim excerpt:

"Adverse consequences of ANTIPSYCHOTICS exhibited by this resident":

  • "Anticholinergic effects, such as constipation, dry mouth, blurred vision, urinary retention, etc. (clinical record)
  • Increase in total cholesterol and triglycerides (clinical record)
  • Akathisia (inability to sit still) (clinical record)
  • Parkinsonism (any combination of tremors, postural unsteadiness, muscle rigidity, pill-rolling of hands, shuffling gait, etc.) (clinical record)
  • Neuroleptic malignant syndrome (high fever with severe muscle rigidity) (clinical record)
  • Blood sugar elevation (clinical record)
  • Cardiac arrhythmias (I0300)
  • Orthostatic hypotension (I0800, clinical record)
  • Cerebrovascular accident or transient ischemic attack (I4500)
  • Falls (J1700-J1900)
  • Tardive dyskinesia (persistent involuntary movement such as tongue thrusting, lip movements, chewing or puckering movements, abnormal limb movements, rocking or writhing trunk movements) (clinical record)
  • Lethargy (D0200D, clinical record)
  • Excessive sedation (clinical record)
  • Depression (D0300, D0600, I5800)
  • Hallucinations (E0100A)
  • Delirium unrelated to medical illness or severe depression (C1600, clinical record)."

Source: RAI manual, Appendix C-71.

Other Articles in this issue of

MDS Alert

View All